Entact Bio

Biotechnology company in the Abingworth investment portfolio focused on therapeutic development.

Investors
1
Categories
biotech, therapeutics

Notes

Entact Bio is a biotechnology company that is part of the Abingworth investment portfolio. Abingworth is a leading life sciences investment firm that focuses on building and supporting innovative healthcare and life sciences companies.

Limited public information is available about Entact Bio's specific therapeutic programs and focus areas.

Team

  • Leadership team information not publicly disclosed

Additional Research Findings

  • Portfolio company of Abingworth
  • Biotechnology company
  • Limited public information available

Sources

Investors

NameLocationTypeStagesPortfolio
AbingworthLondon, UK / Boston, USAbiotech-focused
seedseries-a+3
34